
CKM Syndrome: The New Guideline Turns Heart, Kidney, and Metabolic Health Into a Single Risk Score
The new CKM guideline officially unites heart, kidney, and metabolic health, introducing a stage system from 0 to 4, expanded screening with eGFR/UACR and a PREVENT risk calculator, and consideration of social factors like food stability. It also endorses GLP-1 and SGLT2 medications for eligible patients, emphasizing early lifestyle changes to reverse risk, so know your numbers and discuss your stage with your doctor.









